Showing results (1271-1280 of 2,457) with videos related to

Sort By:
Pageof 246
Molecular Pharmacology|June 18, 2002
Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivativesZhan-Guo Gao, Seong Gon Kim, Kelly A Soltysiak, et al.
Molecular Pharmacology|April 16, 2003
Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptorZhan-Guo Gao, Soo-Kyung Kim, Ariel S Gross, et al.
The Astrophysical Journal. Letters|January 10, 2022
How Sublimation Delays the Onset of Dusty Debris Disk Formation Around White Dwarf StarsJordan K Steckloff, John Debes, Amy Steele, et al.
The American Journal of Cardiology|August 16, 2011
Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemiaStuart Samuel, Barbara Peskin, Bhakti Arondekar, et al.
BMC Pharmacology|November 2, 2011
Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse heartsTina C Wan, Dilip K Tosh, Lili Du, et al.
AJR. American Journal of Roentgenology|February 21, 2004
Sonographic characteristics of peripheral nerve sheath tumorsDavid L Reynolds, Jon A Jacobson, Prasuna Inampudi, et al.
Journal of Occupational and Environmental Medicine|October 14, 2022
A Rapid Nucleic Acid Amplification Test-Based, Conditional Release-to-Work Policy for Health Care Personnel With Symptoms Consistent With COVID-19Mark A Jacobson, Colin Hart, Will Huen, et al.
Journal of Medicinal Chemistry|September 30, 1994
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptorsH O Kim, X D Ji, N Melman, et al.
Medical and Pediatric Oncology|January 1, 1994
LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte SocietyS Ladisch, H Gadner, M Aricò, et al.
The Journal of Biological Chemistry|March 15, 2014
Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerancePrasanna K Dadi, Nicholas C Vierra, Alessandro Ustione, et al.
Pageof 246